The combination of Ara h 2‐sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy
Pediatric Allergy and Immunology · 2023
DOI: 10.1111/pai.14007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Marion Carrette und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Biotherapy, INSERM U1234, CHU Rouen, Université de Rouen Normandie, Rouen, France. Hauptthemen laut MEDLINE: Basophil Degranulation Test, Peanut Hypersensitivity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Most children with peanut sensitisation do not have a clinical peanut allergy (PA). Oral food challenge (OFC) is then necessary to diagnose PA and assess the reactive dose of the allergen. However, OFC is laborious to perform, expensive and stressful. We evaluated whether in vitro tests, such as basophil activation test (BAT), allergen‐specific IgE (sIgE) and their combination, could be used to replace OFC for the diagnosis of PA in children.
Methods
Ninety‐one patients aged 6 months to 18 years with suspected PA were prospectively recruited. These patients then underwent an OFC to assess PA. Whole peanut‐sIgE, Ara h 2‐sIgE, Ara h 8‐sIgE and %CD63 + basophils (CCR3 + /SCC low ) to peanut measured by BAT were investigated for PA diagnosis.
Results
Forty‐one patients had a positive peanut OFC, and the remaining 50 were only sensitised. All patients with Ara h 2‐sIgE >7 kU A /L were allergic to peanut. A threshold of 6% for activated basophils yielded a sensitivity of 95% and a specificity of 54%. All patients with Ara h 2‐sIgE ≤7 kU A /L and BAT ≤6% ( n = 22) had a negative OFC except for one who presented an oral syndrome due to PR‐10 sensitisation.
Conclusions
We have shown that Ara h 2‐sIgE >7 kUA/L is a discriminating threshold for the diagnosis of PA. Furthermore, when Ara h 2‐sIgE ≤7 kUA/L and BAT ≤6%, patients do not need to adjust their diet and, thus, do not need an OFC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Biotherapy, INSERM U1234, CHU Rouen, Université de Rouen Normandie, Rouen, France.
- Department of Paediatrics and Adolescent Medicine, CIC INSERM 1404, EA 2656, CHU Rouen, Université de Rouen Normandie, Rouen, France.
- Department of Clinical Research and Innovation, CHU Rouen, Rouen, France.
- École nationale de la statistique et de l'analyse de l'information (ENSAI), Bruz, France.
ORCID-Profile: Jérémie Martinet
Zitieren
APA
Carrette, M., Couderc, L., Bubenheim, M., Vidal, A., Youssouf, A., Boyer, O., Marguet, C., & Martinet, J. (2023). The combination of Ara h 2‐sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14007
Vancouver
Carrette M, Couderc L, Bubenheim M, Vidal A, Youssouf A, Boyer O, et al. The combination of Ara h 2‐sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.14007
BibTeX
@article{Carrette2023,
author = {Carrette, Marion and Couderc, Laure and Bubenheim, Michael and Vidal, Alexandra and Youssouf, Asmynour and Boyer, Olivier and Marguet, Christophe and Martinet, Jérémie},
title = {The combination of Ara h 2‐sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy},
journal = {Pediatric Allergy and Immunology},
year = {2023},
doi = {10.1111/pai.14007}
}
EUVIMED